AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Provided By GlobeNewswire
Last update: Apr 30, 2025
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Lausanne, Switzerland, April 30, 2025 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today reported results for the quarter ended March 31, 2025, and provided a corporate update.
Read more at globenewswire.com
